July 1, 2010
The PFGRC announces the transfer of the SARS Coronavirus (SARS-CoV) Gateway® Clone set to the Biodefense and Emerging Infections Resources Repository (BEIR)
The PFGRC has transferred the SARS-CoV Gateway® Entry Clone set to BEIR for repository and distribution purposes. The set consists of 27 clones in Gateway vector pDONR 221, (Invitrogen, Inc) and is based on the Genbank accession NC_004718.3. Beginning July 1, 2010 all future SARS-CoV Gateway® Clone distribution activities will be carried out by BEIR.